Atlas Trials

CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL

Clinical trial NCT00586391 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00586391
Sponsor
Baylor College of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B Cell LymphomaChronic Lymphocytic LeukemiaAcute Lymphocytic Leukemia
Start date
2009-02-01
Primary completion
2014-07-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.